LCH Limited

Susi de Verdelon appointed CEO of LCH Limited

Press Release – January 21, 2025 London Stock Exchange Group (LSEG) today announces that Susi de Verdelon has been appointed CEO of LCH Limited. Susi will assume the role in February 2025, subject to regulatory non-objection, and will report to Daniel Maguire, Group Head, LSEG Markets and CEO of LCH Group. The appointment follows the decision of Isabelle Girolami to leave LCH Limited as CEO, … Continue reading Susi de Verdelon appointed CEO of LCH Limited

ROYC

ROYC Appoints Advisory Board to Drive Strategic Growth and Innovation

Press Release – January 20, 2025 – STOCKHOLM – ROYC, a European leader in Platform-as-a-Service for alternative investments, is pleased to announce the formation of a highly experienced Advisory Board with the purpose to assist and advise the Board and company management in key strategic areas such as market expansion and platform development. “Their combined deep expertise in scaling tech companies and sales organizations combined … Continue reading ROYC Appoints Advisory Board to Drive Strategic Growth and Innovation

Finastra

Finastra announces leadership transition: welcoming Chris Walters as new CEO

Press Release – London, UK – January 6, 2025 – Finastra, a global provider of financial services software applications, today announced a significant leadership transition. After nearly a decade of transformative leadership, Simon Paris will step down from his role as Chief Executive Officer. Chris Walters has joined Finastra and will assume the role of Chief Executive Officer. Chris brings a wealth of experience from senior executive leadership positions, driving innovation and scaling … Continue reading Finastra announces leadership transition: welcoming Chris Walters as new CEO

IDRx

GSK Enters Agreement to Acquire IDRx, Inc.

Press Release – January 13, 2025 – PLYMOUTH, Mass. – GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of GIST. Under the agreement, GSK will pay $1 billion upfront, with potential for an additional $150 million success-based … Continue reading GSK Enters Agreement to Acquire IDRx, Inc.

Chemify

Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer

Previously at MeiraGTx, GSK and Novartis, Dr. Leighton will help Chemify scale the company’s operational capacity to meet demand for the design and synthesis of complex small molecules. Press Release – January 10, 2025 – GLASGOW, Scotland – Chemify, a deep tech chemical science company combining chemistry, robotics and AI at scale to digitally design, discover and make new molecules, announced today that Dr. Alastair … Continue reading Chemify Hires Biopharma Veteran Dr. Alastair Leighton as Chief Operating Officer